Moreover, the additional analysis results in the ONCOMINE database (Fig. 1c) further confirmed that CBX3 is highly expressed in breast cancer, cervical cancer, lung cancer, kidney cancer, colorectal cancer, and ovarian (P < 0.01), compared with normal controls. This evidence concerns the gene CBX3 and lung carcinoma.